Compare MTN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTN | TECH |
|---|---|---|
| Founded | 1997 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 9.5B |
| IPO Year | 1997 | 1989 |
| Metric | MTN | TECH |
|---|---|---|
| Price | $159.75 | $58.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $176.50 | $71.23 |
| AVG Volume (30 Days) | 938.6K | ★ 1.8M |
| Earning Date | 12-10-2025 | 02-04-2026 |
| Dividend Yield | ★ 5.49% | 0.55% |
| EPS Growth | ★ 17.26 | N/A |
| EPS | ★ 7.24 | 0.49 |
| Revenue | ★ $2,975,101,000.00 | $1,216,732,000.00 |
| Revenue This Year | $2.69 | $2.33 |
| Revenue Next Year | $3.45 | $7.05 |
| P/E Ratio | ★ $22.34 | $120.21 |
| Revenue Growth | 3.06 | ★ 3.85 |
| 52 Week Low | $129.85 | $46.01 |
| 52 Week High | $196.64 | $79.28 |
| Indicator | MTN | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 66.98 | 42.18 |
| Support Level | $140.00 | $58.75 |
| Resistance Level | $146.91 | $61.20 |
| Average True Range (ATR) | 4.57 | 2.01 |
| MACD | 2.65 | -0.54 |
| Stochastic Oscillator | 88.48 | 13.44 |
Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.